Clinical trial
Clinical Evaluation of Switching to Lithiofor® (Lithium Sulphate Slow -Release, Li-SR Tablets) From Carbolithium® (Lithium Carbonate Immediate-Release, Li-IR, Capsules) in Bipolar Patients, Poorly Tolerant to Lithium Immediate-release Treatment.
NCT03210480 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of Switching to Lithiofor® (Lithium Sulphate Slow -Release, Li-SR Tablets) From Carbolithium® (Lithium Carbonate Immediate-Release, Li-IR, Capsules) in Bipolar Patients, Poorly Tolerant to Lithium Immediate-release Treatment.
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 28, 2017
- Completion date
- September 20, 2019
- Enrollment
- 85 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.